Woodley Farra Manion Portfolio Management’s GSK GSK Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-75,766	Closed	-$3.56M	–	90
2020 Q3	$3.56M	Sell	75,766 -7,676	-9%	-$385K	0.37%	43
2020 Q2	$4.25M	Buy	83,442 +152	+0.2%	+$7.8K	0.44%	36
2020 Q1	$3.94M	Sell	83,290 -2,085	-2%	-$111K	0.47%	36
2019 Q4	$5.01M	Sell	85,375 -230	-0.3%	-$12.8K	0.47%	36
2019 Q3	$4.57M	Sell	85,605 -578	-0.7%	-$29.7K	0.46%	37
2019 Q2	$4.31M	Buy	86,183 +1,368	+2%	+$68.6K	0.43%	40
2019 Q1	$4.43M	Buy	84,815 +8,224	+11%	+$411K	0.48%	34
2018 Q4	$3.66M	Sell	76,591 -3,645	-5%	-$180K	0.44%	40
2018 Q3	$4.03M	Sell	80,236 -1,382	-2%	-$70.2K	0.42%	44
2018 Q2	$4.11M	Buy	81,618 +4,344	+6%	+$219K	0.46%	42
2018 Q1	$3.77M	Buy	77,274 +393	+0.5%	+$18.3K	0.43%	45
2017 Q4	$3.41M	Sell	76,881 -2,961	-4%	-$137K	0.37%	47
2017 Q3	$4.05M	Buy	79,842 +3,235	+4%	+$164K	0.47%	43
2017 Q2	$4.13M	Buy	76,607 +1,312	+2%	+$69.9K	0.53%	42
2017 Q1	$3.97M	Buy	75,295 +10,760	+17%	+$546K	0.52%	39
2016 Q4	$3.11M	Buy	64,535 +5,372	+9%	+$265K	0.42%	45
2016 Q3	$3.19M	Buy	59,163 +2,840	+5%	+$156K	0.47%	40
2016 Q2	$3.05M	Buy	56,323 +7,044	+14%	+$371K	0.47%	43
2016 Q1	$2.5M	Buy	49,279 +10,500	+27%	+$523K	0.41%	45
2015 Q4	$1.96M	Sell	38,779 -812	-2%	-$41.4K	0.34%	47
2015 Q3	$1.9M	Buy	39,591 +40	+0.1%	+$2.08K	0.38%	42
2015 Q2	$2.06M	Sell	39,551 -2,380	-6%	-$134K	0.4%	33
2015 Q1	$2.42M	Buy	41,931 +12,120	+41%	+$695K	0.42%	31
2014 Q4	$1.59M	Buy	29,811 +5,400	+22%	+$302K	0.29%	48
2014 Q3	$1.4M	Buy	24,411 +100	+0.4%	+$6.13K	0.26%	48
2014 Q2	$1.63M	Buy	24,311 +840	+4%	+$56.9K	0.3%	41
2014 Q1	$1.57M	Buy	23,471 +217	+0.9%	+$14.7K	0.31%	39
2013 Q4	$1.55M	Buy	23,254 +664	+3%	+$43.1K	0.28%	37
2013 Q3	$1.42M	Buy	22,590 +982	+5%	+$63.2K	0.29%	36
2013 Q2	$1.35M	Buy	+21,608	New	+$1.37M	0.29%	40

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's GSK Position: Q4 2020 in Review

Woodley Farra Manion Portfolio Management sold out of GSK (GSK) in Q4 2020, closing a stake of 75,766 shares — an estimated $3.56M sold.

Woodley Farra Manion Portfolio Management first reported a position in GSK in Q2 2013 and held it in 30 quarters. The position peaked at $5.01M in Q4 2019. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Woodley Farra Manion Portfolio Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Woodley Farra Manion Portfolio Management sold 75,766 GSK shares in Q4 2020, an estimated $3.56M.
Woodley Farra Manion Portfolio Management first reported a position in GSK in Q2 2013 and held it in 30 quarters.
Woodley Farra Manion Portfolio Management's GSK position peaked at $5.01M in Q4 2019.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q4 2020, filed 5 Feb 2021.